These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 19764478)

  • 1. [Role of thrombin receptors in vascular physiology and pathophysiology].
    Hirano K
    Fukuoka Igaku Zasshi; 2009 Jul; 100(7):248-57. PubMed ID: 19764478
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of the endothelium in the vascular effects of the thrombin receptor (protease-activated receptor type 1) in humans.
    Gudmundsdóttir IJ; Lang NN; Boon NA; Ludlam CA; Webb DJ; Fox KA; Newby DE
    J Am Coll Cardiol; 2008 May; 51(18):1749-56. PubMed ID: 18452780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prothrombin/thrombin and the thrombin receptors PAR-1 and PAR-4 in the brain: localization, expression and participation in neurodegenerative diseases.
    Sokolova E; Reiser G
    Thromb Haemost; 2008 Oct; 100(4):576-81. PubMed ID: 18841278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of thrombin and its receptor, the protease-activated receptor 1, in the pathophysiology of glomerular injury.
    Rondeau E; Sraer JD; Nguyen G; Hé CJ; Zacharias U; Xu Y
    Adv Nephrol Necker Hosp; 1999; 29():17-34. PubMed ID: 10561735
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of protease-activated receptors in the vascular system.
    Hirano K; Kanaide H
    J Atheroscler Thromb; 2003; 10(4):211-25. PubMed ID: 14566084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protease-activated receptors in cardiovascular diseases.
    Leger AJ; Covic L; Kuliopulos A
    Circulation; 2006 Sep; 114(10):1070-7. PubMed ID: 16952995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical implications of the contrasting effects of in vivo thrombin receptor activation (protease-activated receptor type 1) on the human vasculature.
    Cleator JH; Vaughan DE
    J Am Coll Cardiol; 2008 May; 51(18):1757-9. PubMed ID: 18452781
    [No Abstract]   [Full Text] [Related]  

  • 8. [Thrombin induced tumour growth - pharmacological control].
    Nowak G; Lopez M; Zieger M
    Hamostaseologie; 2007 May; 27(2):105-10. PubMed ID: 17479173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombin and vascular development: a sticky subject.
    Moser M; Patterson C
    Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):922-30. PubMed ID: 12807713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled delivery of nitric oxide inhibits leukocyte migration and prevents vasospasm in haptoglobin 2-2 mice after subarachnoid hemorrhage.
    Momin EN; Schwab KE; Chaichana KL; Miller-Lotan R; Levy AP; Tamargo RJ
    Neurosurgery; 2009 Nov; 65(5):937-45; discussion 945. PubMed ID: 19834407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor Xa: at the crossroads between coagulation and signaling in physiology and disease.
    Borensztajn K; Peppelenbosch MP; Spek CA
    Trends Mol Med; 2008 Oct; 14(10):429-40. PubMed ID: 18774340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular biology. Platelets and proteases.
    Brass S
    Nature; 2001 Sep; 413(6851):26-7. PubMed ID: 11544507
    [No Abstract]   [Full Text] [Related]  

  • 13. [Thrombin receptor in thrombosis].
    Maruyama I
    Nihon Naika Gakkai Zasshi; 1997 Jun; 86(6):981-5. PubMed ID: 9340367
    [No Abstract]   [Full Text] [Related]  

  • 14. [Uremic coagulopathy. Role of thrombin].
    Camici M; Sagripanti A
    Minerva Urol Nefrol; 2000 Jun; 52(2):67-72. PubMed ID: 11085063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coagulation signals for intact blood vessels.
    van Hinsbergh VW
    Lancet; 2002 Jun; 359(9322):1958-60. PubMed ID: 12076547
    [No Abstract]   [Full Text] [Related]  

  • 16. Sol Sherry lecture in thrombosis: how thrombin 'talks' to cells: molecular mechanisms and roles in vivo.
    Coughlin SR
    Arterioscler Thromb Vasc Biol; 1998 Apr; 18(4):514-8. PubMed ID: 9555855
    [No Abstract]   [Full Text] [Related]  

  • 17. Thrombin-induced endothelial cell dysfunction.
    Rabiet MJ; Plantier JL; Dejana E
    Br Med Bull; 1994 Oct; 50(4):936-45. PubMed ID: 7804740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current perspective on antithrombin drugs.
    McGregor JL
    Pathophysiol Haemost Thromb; 2002; 32 Suppl 3():29-35. PubMed ID: 12811009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral vasospasm in patients suffering from aneurysmal subarachnoid hemorrhage: an unresolved diagnostic and therapeutic challenge.
    Missler U
    Crit Care Med; 2009 Mar; 37(3):1150-1. PubMed ID: 19237943
    [No Abstract]   [Full Text] [Related]  

  • 20. Thrombin and its receptor in growth control.
    Van Obberghen-Schilling E; Vouret-Craviari V; Chen YH; Grall D; Chambard JC; Pouysségur J
    Ann N Y Acad Sci; 1995 Sep; 766():431-41. PubMed ID: 7486688
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.